We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Retrospective analysis indicates Rituximab may improve outcomes in patients with ANCA-associated vasculitis, compared to Cyclophosphamide.
Not applicable. This is not a clinical trial but a retrospective analysis.
No takes yet. Share an insight, caveat, or question.
Sheng Chen (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: